Roundhill Investments - GLP-1 & Weight Loss ETF
Price through Nov 16, 2026 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.
OZEM price
Table
| Date | OZEM close |
|---|---|
| Oct 16, 2026 | $29.25 |
| Oct 19, 2026 | $29.08 |
| Oct 20, 2026 | $30.21 |
| Oct 21, 2026 | $30.00 |
| Oct 22, 2026 | $29.98 |
| Oct 23, 2026 | $29.64 |
| Oct 26, 2026 | $29.52 |
| Oct 27, 2026 | $29.50 |
| Oct 28, 2026 | $29.75 |
| Oct 29, 2026 | $30.35 |
| Oct 30, 2026 | $30.70 |
| Nov 2, 2026 | $30.57 |
| Nov 3, 2026 | $30.26 |
| Nov 4, 2026 | $31.35 |
| Nov 5, 2026 | $30.65 |
| Nov 6, 2026 | $30.89 |
| Nov 9, 2026 | $31.76 |
| Nov 10, 2026 | $31.72 |
| Nov 11, 2026 | $31.73 |
| Nov 12, 2026 | $31.23 |
| Nov 13, 2026 | $31.41 |
| Nov 16, 2026 | $30.75 |
Recent fund-flow records are unavailable, while the price has returned -10.0% so far this year. At 0.59% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 20.13% | $1431.67 | -0.8% | ||
| 2 | NVONOVO NORDISK A S | 10.76% | $41.60 | -0.1% | ||
| 3 | PFEPFIZER | 5.64% | $28.86 | -0.1% | ||
| 4 | KLRAKAILERA THERAPEUTICS INC | 4.84% | $12.57 | -5.3% | ||
| 5 | VKTXVIKING THERAPEUTICS | 3.91% | $26.80 | -8.3% | ||
| 6 | AZNASTRAZENECA | 3.19% | $184.02 | -0.2% | ||
| 7 | AMGNAMGEN | 2.96% | $462.32 | -0.7% | ||
| 8 | GPCRSTRUCTURE THERAPEUTICS | 2.94% | $18.57 | -7.2% | ||
| 9 | MBXMBX Biosciences | 1.74% | $53.12 | -5.0% | ||
| 10 | GILDGILEAD SCIENCES | 1.38% | $167.58 | -0.3% | ||
| 11 | FGXXXFirst American Government Obligations Fund 12/01/2031 | 0.30% | — | — | — | |
| 12 | GUBRA.COGubra A/S | 2.12% | — | — | — | |
| 13 | ROP.SWRoche Holding AG | 2.68% | — | — | — | |
| 14 | —Cash & Other | 0.71% | — | — | — | |
| 15 | ZEAL.COZealand Pharma A/S | 3.09% | — | — | — |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 29Sector weights
- Healthcare100%
- Materials0.35%
- Consumer Discretionary0.29%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Materials | 0.35% |
| Consumer Discretionary | 0.29% |
Country weights
- United States45.8%
- Denmark17.38%
- China13.15%
- Japan6.56%
- Hong Kong5.22%
- United Kingdom4.33%
- South Korea4.03%
- Switzerland3.54%
Show as table
| Item | Value (%) |
|---|---|
| United States | 45.8% |
| Denmark | 17.38% |
| China | 13.15% |
| Japan | 6.56% |
| Hong Kong | 5.22% |
| United Kingdom | 4.33% |
| South Korea | 4.03% |
| Switzerland | 3.54% |
| 1 week | -3.1% |
| 1 month | +5.1% |
| 3 months | -6.9% |
| 6 months | -0.3% |
| YTD | -10.0% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 20.1% of the book; the top ten carry 71%. Spread across 24+ names, it behaves like roughly 12 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $43M | $45M |
| AMGN AMGEN | $3M | $3M |
| GILD GILEAD SCIENCES | $2M | $2M |
| NVO NOVO NORDISK A S | $2M | $2M |
| VKTX VIKING THERAPEUTICS | $1M | $1M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES